Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer.

ESMO open·2026
Same author

Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration - The OCTOPUS cohort study.

Journal francais d'ophtalmologie·2025
Same author

Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration - The SWIFT study.

Journal francais d'ophtalmologie·2025
Same author

[Diagnostic approach and treatment paradigm in atrophic age related macular degeneration: Recommendations of the France Macula Federation].

Journal francais d'ophtalmologie·2025
Same author

Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Cognitive bias evaluation on the choice of treatment in common retinal disorders among retina specialists in 2023.

Journal francais d'ophtalmologie·2024

Related Experiment Video

Updated: Jun 4, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

[SPA-2: semiology for phenotyping AMD: atrophic AMD].

R Tahiri Joutei Hassani1, V Le Tien, F Canoui-Poitrine

  • 1Service d'ophtalmologie, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France.

Journal Francais D'Ophtalmologie
|February 2, 2011
PubMed
Summary

Developing a reproducible classification for atrophic age-related macular degeneration (AMD) is crucial. This study found good agreement on the presence of atrophy but poor agreement on its size, suggesting areas for improvement in AMD classification.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Experiment Videos

Last Updated: Jun 4, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Genetics

Context:

  • Age-related macular degeneration (AMD) classification requires homogeneous subgroups for clinical and genetic studies.
  • Current atrophic AMD classification lacks consensus and reproducibility.
  • Advanced imaging techniques like OCT and angiography are used in AMD assessment.

Purpose:

  • To evaluate a selected list of items for atrophic AMD classification using multiple imaging modalities.
  • To assess the reproducibility and agreement of different items in classifying atrophic AMD.
  • To propose modifications for a more discriminant and reproducible atrophic AMD classification grid.

Summary:

  • Ten items for atrophy were assessed by five experienced readers and an expert using various imaging techniques for 20 eyes with atrophic AMD.
  • The highest inter-observer agreement (Kappa=1) was for the presence of atrophy.
  • The lowest inter-observer agreement was for the size of atrophy (Kappa=-0.0286±0.0769 to 0.1813±0.0835).

Impact:

  • The study highlights the complexity and lack of consensus in current atrophic AMD classification.
  • The proposed classification grid shows satisfactory inter-observer agreement for most items.
  • Modifications are suggested to enhance the discriminant and reproducible nature of the atrophic AMD classification grid.